Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

5% minoxidil foam once daily works as well as 2% minoxidil solution twice daily for female hair growth and is more convenient.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Menopause affects hair and skin; more research needed for treatment.